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ABSTRACT
Objectives: Idiopathic recurrent pregnancy loss (IRPL) is one of the most troublesome complications of pregnancy. Several 
researches were also conducted to search the possible association with ACE I/D polymorphism and IRPL. In the light of 
these reports, this case-control study was investigated to genotypes and alleles of ACE I/D polymorphism in IRPL group 
and control group.
Material and methods: Overall, 1176 subjects (1007 cases, 169 controls) were investigated. Allele genotype distributions 
were determined by PCR method in both groups. Differences in genotype and allele frequencies between groups were 
investigated by Pearson chi-square tests. The odds ratio (OR) and 95% confidence intervals (95% CI) were also determined.
Results: For the ACE I/D polymorphism I and D allele frequencies were in the control and case groups respectively; 49.4 and 
41.6%, 50.6 and 58.4%. The genotypes of ACE for I/D observed in control and case group respectively were as follows; II 
(27.2 and 17.9), ID (44.4 and 47.4) and DD (28.4 and 34.7). Regarding the distribution of D allele and genotypes containing 
D allele, we observed significant statistical differences between case and control groups. 
Conclusions: Our results showed that the ACE I/D polymorphism was associated with IRPL, and that women that carried DD 
or ID genotypes had a 72% elevated risk of developing IRPL than women with the II genotype (OR (95% CI): 1.72 (1.181–2.5)). 
This odds ratio was found to be 1.61 in a case-control study and 1.28 in a meta-analysis study compiling 11 separate studies, 
which is consistent with our study data. 
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INTRODUCTION
Idiopathic recurrent pregnancy loss (IRPL) is one of the 
most troublesome complications of pregnancy. IRPL is de-
fined differently by several groups. The diversified descrip-
tion is as follows: loss of two or more consecutive pregnan-
cies before four months and three or more sequent pregnan-
cy loss before the 22nd-24rd week of pregnancy [1–3]. IRPL 
affects approximately 1–5% of women who are pregnant, 
according to the 'IRPL definition' of two or three consecutive 
pregnancy loss. This percentage increases with age [4]. Cur-
rently, several well-known risk factors of recurrent miscar-
riage are described: chromosomal abnormalities, polycystic 
ovary syndrome, thrombophilia, hypothyroidism, anatomic 
anomalies, endocrine disturbances, obesity, infections, and 
environmental and nutritional factors [5]. However, more 
than 50% of women with IRPL have no precise reason of 
pregnancy loss [6]. Genetic causes account for only 2–5% 
of the defined causes [7]. Despite this low level, many dif-
ferent studies have been conducted on genetic changes in 
the etiology of IRPL. The most marked relationship between 
these studies is related to numerical and structural chromo-
some anomalies. However, many gene polymorphisms have 
also been investigated, especially these related to coagula-
tion cascade, as the successful pregnancy is dependent on 
a sensitive balance between fibrinolysis and coagulation. 
Until this date, about the topic the most studied genes and 
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polymorphisms were plasminogen activator inhibitor-1 (PAI-
1) 4G/5G, methylenetetrahydrofolate reductase (MTHFR) 
C677T, factor V-Leiden (G1691A), factor-2 20210G > A and 
angiotensin-converting enzyme (ACE) insertion/deletion 
(I/D) polymorphism [7–9]. The ACE is located on long arm 
of chromosome of 17 with 25 introns and 26 exons and 
contains 21 kilobases (kb) of genomic DNA. ACE plays a key 
role in the rennin-angiotensin-aldosterone system (RAAS) 
and is related in the transformation of angiotensin I to ac-
tive angiotensin II, a powerful vasoconstrictor [10]. An I/D 
polymorphism of the ACE forming of the insertion or dele-
tion of a 287 basepair (bp) Alu sequence component in 
intron 16 is associated with the serum ACE level (rs4340). 
The existence of the D/D genotype or D allele is associated 
with high serum and plasma ACE activity. The D/D genotype 
also increases procuration of angiotensin II from angioten-
sin I and is associated with elevated levels of PAI-1, which 
result in the decreased levels of fibrinolysis. Furthermore, 
ACE degrades bradykinin, a very potent vasodilator [11]. 
Several researches were also conducted to search the pos-
sible association with ACE I/D polymorphism and IRPL. The 
potential role of ACE I/D polymorphism in IRPL pathogenesis 
has been controversial [3, 9, 12–15]. 
Objectives
This current case-control study was investigated to gen-
otypes and alleles of ACE I/D polymorphism in two groups 
from the south-eastern part of Turkey. The case group with 
two unexplained consecutive pregnancy losses and the 
control group with at least one live birth and no history of 
pregnancy loss.
MATERIALS AND METHODS
Overall, 1176 subjects (1007 cases, 169 controls) were 
investigated between October 2016 and August 2018. Of 
those, 1007 women had a history of ≥ 2 consecutive preg-
nancy losses and 169 fertile women had at least one live 
birth and no history of pregnancy loss. For this purpose, 
the participants with following evidence were excluded 
from each group; structural uterine abnormality, chromo-
somal abnormalities, hormonal imbalance (TSH, FSH, LH, 
prolactin), anti-nuclear antibodies, antiphospholipid an-
tibodies and lupus anticoagulant. All women were from 
Sanliurfa province in the south-east of Turkey. The study 
was approved by the Institutional Review Board of Faculty of 
Medicine in Harran University (Ethics Committee Document 
Number: 04.01.2018/01-12) and the study was conducted 
in accordance with 2013 Declaration of Helsinki. All women 
included in the study signed the informed consent form. 
Complete blood samples were taken from the antecubital 
vein via vacutainer tubes comprising ethylenediaminetet-
raacetic acid (EDTA) (BD, Franklin Lakes, NJ). DNA was iso-
lated from blood samples using Magpurix Blood DNA Extrac-
tion Kit 200 (Zinexts LSC, New Taipei City, Taiwan [R.O.C.]). 
Quantitative-purity determinations and fluorometry analy-
sis were performed (NanoDrop 8000, Thermo-Fisher Scien-
tific, DE, USA). To analyze ACE I/D polymorphism, genomic 
DNA was amplified by polymerase chain reaction (PCR) 
using specific primers: forward: 5’-CTGGAGACCACTCCCATC-
CTTTCT-3’; reverse:5’ GATGTGGCCATCACATTCGTCAGAT-3’ 
(Sentegen Biotech, Ankara, TR). The PCR method used for 
this polymorphism was performed as previously described 
[16]. DNA fragments were separated by 3% agarose elec-
trophoresis and described by ethidium bromide staining. 
Three types of ACE PCR products were described a 190 bp 
band corresponding to the D/D genotype, a 490 bp band 
corresponding to I/I genotype, or a compound of 190 and 
490 bp bands corresponding to the I/D genotype. Allele 
and genotype frequencies were checked for deviation from 
Hardy-Weinberg equilibrium by Pearson chi-square analy-
sis. Differences in genotype and allele frequencies between 
groups were investigated by Pearson chi-square tests. The 
odd ratio (OR) and 95% confidence intervals (95% CI) were 
also determined. All statistical data were analyzed using 
statistical package for social sciences (SPSS) software ver-
sion 23.0 (IBM SPSS, Chicago, IL, USA) program. For all tests 
p < 0.05 was considered as significant.
Results
The mean age of the control group and case group was 
26.41 ± 6.29 years (ranged between 19–45, median 26), and 
25.88 ± 5.76 years (ranged between 19-43, median 25), re-
spectively. There was no significant difference between the 
case and control groups (p > 0.05). For the ACE I/D polymor-
phism I and D allele frequencies were in the control and case 
groups respectively; 49.4 and 41.6%, 50.6 and 58.4%. The 
genotypes of ACE for I/D observed in control and case group 
respectively were as follows; II (27.2 and 17.9), ID (44.4 and 
47.4) and DD (28.4 and 34.7). The genotype and allele fre-
quencies in the control and case groups were checked for 
deviation from Hardy-Weinberg equilibrium. No deviation 
was observed (Tab. 1). The odds ratio, confidence interval, 
chi-square test and p value are displayed in Table 1. The most 
frequent genotype was ID in both groups. Regarding the 
distribution of D allele and genotypes containing D allele, 
we observed significant statistical differences between case 
and control groups. 
DISCUSSION 
In this study, we have tried to examine ACE I/D polymor-
phism allelic frequencies and genotypes and its association 
with IRPL among south-eastern Turkish women. ACE I/D pol-
ymorphism has so far been associated with many conditions 
such as stroke, coronary heart disease, diabetic nephropathy, 
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athletic performance, hypertension, preeclampsia and IRPL 
[15, 17, 18]. The probable association between IRPL and ACE 
I/D polymorphism is based on the theory that degenerated 
hemostasis, excess fibrin accumulations in spiral arteries 
and impedes perfusion secondary to platelet aggregation 
could lead to pregnancy loss. The D allele was shown to be 
associated with a high level of ACE in serum, which enhances 
the formation of angiotensin II from angiotensin I, thus in-
creasing the risk of thrombotic episodes. Some studies have 
reported a link between the D allele and risk of thrombosis 
[11, 13, 15]. Data by several regions demonstrated that the 
D allele and DD genotype leads to a high PAI-1 level which 
reduced fibrinolysis and thus correlated with an increased 
risk of IRPL [9, 12, 15]. Many studies have been managed to 
explore the link between ACE I/D polymorphism alleles and 
genotypes and IRPL, but the results of these studies differ 
from each other [13–15, 19–24]. Our results showed that the 
ACE I/D polymorphism was associated with IRPL, and that 
women that carried DD or ID genotypes had a 72% elevated 
risk of developing IRPL than women with the II genotype [OR 
(95% CI): 1.72 (1.181–2.5)]. This odds ratio was found to be 
1.61 in a case-control study and 1.28 in a meta-analysis study 
compiling 11 separate studies, which is consistent with our 
study data [13, 25]. In a study conducted in our country in 
2012, the relationship between ACE I/D polymorphism and 
IRPL was found to be significant at a high level [26].
CONCLUSIONS
The genotype and allele distribution of the ACE I/D poly-
morphism influenced the risk of IRPL in the south-east of 
Turkey, confirming the findings in the north-west of Turkey. 
The most valuable aspect of our work is that it has a large 
sample and is a prospective case-control study. Examina-
tion of the PAI-1 level could add value to this study, but 
unfortunately, this was not possible. Polymorphism studies 
in different societies, with a high number of participants, 
will undoubtedly become more valuable with the work to 
be done in the coming years.
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